ArticleOncoimmunology2026

KRAS-elicited PDIA6 blocks PERK-dependent immunogenic cell death in pancreatic carcinoma.

Liwei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.